Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma

Rozeman, EA (author)

Hoefsmit, EP (author)

Reijers, ILM (author)

show more...

Saw, RPM (author)

Versluis, JM (author)

Krijgsman, O (author)

Dimitriadis, P (author)

Sikorska, K (author)

van de Wiel, BA (author)

Eriksson, H (author)

Karolinska Institutet

Gonzalez, M (author)

Acosta, AT (author)

Grijpink-Ongering, LG (author)

Shannon, K (author)

Haanen, JBAG (author)

Stretch, J (author)

Ch'ng, S (author)

Nieweg, OE (author)

Mallo, HA (author)

Adriaansz, S (author)

Kerkhoven, RM (author)

Cornelissen, S (author)

Broeks, A (author)

Klop, WMC (author)

Zuur, CL (author)

van Houdt, WJ (author)

Peeper, DS (author)

Spillane, AJ (author)

van Akkooi, ACJ (author)

Scolyer, RA (author)

Schumacher, TNM (author)

Menzies, AM (author)

Long, GV (author)

Blank, CU (author)

show less...

 (creator_code:org_t)

2021-02-08

2021

English.

In: Nature medicine. - : Springer Science and Business Media LLC. - 1546-170X .- 1078-8956. ; 27:2, s. 256-

Related links:

http://kipublication...

show more...

https://doi.org/10.1...

show less...

• Journal article (peer-reviewed)